Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fubotv Inc (FUBO) vs Tilray Brands Inc (TLRY) Price & Performance

Fubotv IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Fubotv Inc vs Tilray Brands Inc — how do they compare? Fubotv Inc trades at $8.94 (market cap $1.02B), while Tilray Brands Inc trades at $3.51 (market cap $530.54M). The key difference: Fubotv Inc is the larger of the two by market cap, and Fubotv Inc is more actively traded (978,631 versus 9,099,075). Which is the better fit depends on your goals — on Pluang, investors hold Fubotv Inc for 35 Days and Tilray Brands Inc for 31 Days on average.

FUBOTLRY
Market Cap
$1.02B$530.54M
Volume
978,6319,099,075
Sector
MediaHealth
52-Week High
$48.96$21.00
52-Week Low
$8.09$3.57
Typical Hold Time
35 Days31 Days
Enterprise Value
$1.19B$684.46M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fubotv Inc

FUBO trades at $9.03, down 2.38% today, with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with revenue growth to $1.62B in 2024 and projected net income of $123M in 2025, representing a significant turnaround from previous losses. Recent developments include new sports streaming agreements with NHL teams and expanded partnerships with The Athletic, positioning the company for continued subscriber growth.

FUBO presents a compelling turnaround story with deep valuation discounts (P/E 2.43, P/S 0.19) and analyst consensus target of $63.38 suggesting 600%+ upside. However, risks include persistent cash flow challenges, high debt levels, and intense streaming competition. The Disney partnership and sports content expansion provide catalysts, but execution risk remains elevated given the company's history of losses.

Tilray Brands Inc

Tilray Brands (TLRY) trades at $3.50, down 5.79% on the day and near its 52-week low. The stock shows bearish technical signals with negative moving averages and recent earnings misses across four consecutive quarters. Despite revenue growth to $821 million in 2025, the company reported a substantial net loss of $2.19 billion, driven by impairment charges and high operating costs. Analyst sentiment remains cautious with 65% hold ratings, though the consensus price target of $65.01 suggests significant potential upside from current levels.

The outlook remains challenging with persistent profitability issues and negative cash flow from operations. Investment opportunity exists if Tilray can achieve projected 2026 revenue growth to $915 million and reduce losses. Key risks include ongoing operational inefficiencies, competitive pressures in the cannabis market, and regulatory uncertainty. The stock's current valuation at 0.44 P/S and 0.33 P/B may attract value investors betting on a turnaround.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FUBO
100% Buy0% Sell
Avg holding period · 35 Days
TLRY
54% Buy46% Sell
Avg holding period · 31 Days

Top news

Latest headlines on both assets

About Fubotv Inc

FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, fuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offer subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segments of the group are Streaming and Online wagering, of which a majority of revenue is derived from the Streaming segment. It has a business presence in the U.S. and other international countries.

Read more on FUBO →

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →